Amyloid-Β neurotoxicity restricts glucose window for neuronal survival in rat hippocampal slice cultures

Experimental Gerontology

Volumn 45, Issue 11, 2010, Pages 904-908

  Wang, Xiaonan ^a,b   Song, Xiuzhen ^a   Takata, Toshihiro ^a   Miichi, Yoshiaki ^a   Yokono, Koichi ^a   Sakurai, Takashi ^a,c  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b DALIAN MEDICAL UNIVERSITY   (China)

^c NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

Alzheimer's disease; Amyloid ; Diabetes; Hyperglycemia; Hypoglycemia; Oxidative stress

Indexed keywords

AMYLOID BETA PROTEIN[25-35]; GLUCOSE; PYRUVIC ACID; REACTIVE OXYGEN METABOLITE;

ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; CULTURE MEDIUM; HIPPOCAMPUS; HYPERGLYCEMIA; HYPOGLYCEMIA; NERVE CELL NECROSIS; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; TISSUE CULTURE;

AMYLOID BETA-PEPTIDES; ANIMALS; BLOOD GLUCOSE; CELL SURVIVAL; HIPPOCAMPUS; HYPERGLYCEMIA; HYPOGLYCEMIA; NEURONS; NEUROTOXINS; OXIDATIVE STRESS; RATS; RATS, WISTAR;

RATTUS;

EID: 77957810913     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exger.2010.07.004     Document Type: Article

References (24)

1. Biessels G.J., Staekenborg S., Brunner E., Brayne C., Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 2006, 5:64-74.
2. Nishikawa T., Edelstein D., Du X., Yamagishi S., Matsumura T., Kaneda Y., Yorek M., Beebe D., Oates P., Hammes H., Giardino I., Brownlee M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000, 404:787-790.
3. Gironès X., Guimerà A., Cruz-Sánchez C.Z., Ortega A., Sasaki N., Makita Z., Lafuente J.V., Kalaria R., Cruz-Sánchez F.F. N epsilon-carboxymethyllysine in brain aging, diabetes mellitus, and Alzheimer's disease. Free Radic. Biol. Med. 2004, 36:1241-1247.
4. Whitmer R.A., Karter A.J., Yaffe K., Quesenberry C.P., Selby J.V. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA 2009, 301:1565-1572.
5. Townsend M., Mehta T., Selkoe D.J. Soluble Abeta inhibits specific signal transduction cascades common to the insulin receptor pathway. J. Biol. Chem. 2007, 282:33305-33312.
6. Regan C., Katona C., Walker Z., Hooper J., Donovan J., Livingston G. Relationship of vascular risk to the progression of Alzheimer disease. Neurology 2006, 67:1357-1362.
7. Mielke M., Rosenberg P., Tschanz J., Cook L., Corcoran C., Hayden K., Norton M., Rabins P., Green R., Welsh-Bohmer K., Breitner J., Munger R., Lyketsos C. Vascular factors predict rate of progression in Alzheimer disease. Neurology 2007, 69:1850-1858.
8. Sanz C., Andrieu S., Sinclair A., Hanaire H., Vellas B. Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease. Neurology 2009, 73:1359-1366. REAL.FR Study Group.
9. Helzner E.P., Luchsinger J.A., Scarmeas N., Cosentino S., Brickman A.M., Glymour M.M., Stern Y. Contribution of vascular risk factors to the progression in Alzheimer disease. Arch. Neurol. 2009, 66:343-348.
10. Shaw J.E., de Courten M., Boyko E.J., Zimmet P.Z. Impact of new diagnostic criteria for diabetes on different populations. Diab. Care 1999, 22:762-766.
11. Yaffe K., Blackwell T., Kanaya A.M., Davidowitz N., Barrett-Connor E., Krueger K. Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology 2004, 63:658-663.
12. Wang X.N., Takata T., Sakurai T., Yokono K. Different effects of monocarboxylates on neuronal survival and Β-amyloid toxicity. Eur. J. Neurosci. 2007, 26:2142-2150.
13. Mattson M.P. Pathways towards and away from Alzheimer's disease. Nature 2004, 430:631-639.
14. Wang C.N., Chi C.W., Lin Y.L., Chen C.F., Shiao Y.J. The neuroprotective effects of phytoestrogens on amyloid Β protein-induced toxicity are mediated by abrogating the activation of caspase cascade in rat cortical neurons. J. Biol. Chem. 2001, 276:5287-5295.
15. Suh S., Aoyama K., Matsumori Y., Liu, Swanson R. Pyruvate administered after severe hypoglycemia reduces neuronal death and cognitive impairment. Diabetes 2005, 54:1452-1458.
16. Suh S., Shin B., Ma H., Van Hoecke M., Brennan A., Yenari M., Swanson R. Glucose and NADPH oxidase drive neuronal superoxide formation in stroke. Ann. Neurol. 2008, 64:654-663.
17. Montiel T., Quiroz-Baez R., Massieu L., Arias C. Role of oxidative stress on beta-amyloid neurotoxicity elicited during impairment of energy metabolism in the hippocampus: protection by antioxidants. Exp. Neurol. 2006, 200:496-508.
18. Suh S.W., Gum E.T., Hamby A.M., Chan P.H., Swanson R.A. Hypoglycemic neuronal death is triggered by glucose reperfusion and activation of neuronal NADPH oxidase. J. Clin. Invest. 2007, 117:910-918.
19. Van den Berghe G., Wouters P., Weekers F., Verwaest C., Bruyninckx F., Schetz M., Vlasselaers D., Ferdinande P., Lauwers P., Bouillon R. Intensive insulin therapy in the critically ill patients. N Engl J. Med. 2001, 345:1359-1367.
20. Diringer M.N. Is aggressive treatment of hyperglycemia for everyone?. Crit. Care Med. 2006, 34:930-931.
21. Bilotta F., Spinelli A., Giovannini F., Doronzio A., Delfini R., Rosa G. The effect of intensive insulin therapy on infection rate, vasospasm, neurologic outcome, and mortality in neurointensive care unit after intracranial aneurysm clipping in patients with acute subarachnoid hemorrhage: a randomized prospective pilot trial. J. Neurosurg. Anesthesiol. 2007, 19:156-160.
22. Oddo M., Schmidt J.M., Carrera E., Badjatia N., Connolly E.S., Presciutti M., Ostapkovich N.D., Levine J.M., Le Roux P., Mayer S.A. Impact of tight glycemic control on cerebral glucose metabolism after severe brain injury: a microdialysis study. Crit. Care Med. 2008, 36:3233-3238.
23. Brody D., Magnoni S., Schwetye K., Spinner M., Esparza T., Stocchetti N., Zipfel G., Holtzman D. Amyloid-beta dynamics correlate with neurological status in the injured human brain. Science 2008, 321:1221-1224.
24. Hu X., Crick S.L., Bu G., Frieden C., Pappu R.V., Lee J.M. Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-beta peptide. Proc. Natl Acad. Sci. USA 2009, 106:20324-20329.